SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Other Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Other non-current liabilities of $0 in Q1 FY2026
Q1 FY2026 other non-current liabilities was $0.
Context
- Other non-current liabilities amounted to 0.0% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 204.54M USD
- Year-over-year change
- —
| Period | Period end | Other Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 204.54M | — |
Other Non-current Liabilities vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-current liabilities is compared through growth and share of total assets rather than absolute size.
- Other non-current liabilities amounts to 0.0% of total assets for SGP, versus a peer median of 1.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $808M USD | -14.3% | +33.7% | 2.6% | |
| Jun 2026 | $435M USD | -19.3% | +4.6% | 3.1% | |
| Jun 2026 | $32.43M USD | +5.4% | — | 3.5% | |
| Mar 2026 | $12.98M USD | -7.3% | +22.9% | 1.8% | |
| Apr 2026 | $6.48M USD | +9.5% | +43.9% | 1.4% | |
| Mar 2026 | CHF 1.65M CHF | +27.1% | +144.9% | 0.7% | |
| Mar 2026 | $55K USD | -68.9% | -47.5% | 0.0% | |
| Mar 2026 | $30K USD | +57.9% | -70.7% | 0.0% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $0 USD | — | — | 0.0% |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding SGP) | — | -0.9% | +22.9% | 1.4% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.